Medicalgorithmics S.A. (MDG.WA)
PLN 17.1
(3.89%)
PLN 17.1
(3.89%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.23 Million PLN | -88.91% |
| 2022 | 21.2 Million PLN | 128.7% |
| 2021 | -2.2 Million PLN | -269.58% |
| 2020 | -23.03 Million PLN | -207.63% |
| 2019 | 18.37 Million PLN | -50.4% |
| 2018 | 37.01 Million PLN | -28.49% |
| 2017 | 53.54 Million PLN | -0.56% |
| 2016 | 52.48 Million PLN | 109.53% |
| 2015 | 18.92 Million PLN | 33.81% |
| 2014 | 18.6 Million PLN | 39.17% |
| 2013 | 13.95 Million PLN | 43.57% |
| 2012 | 9.7 Million PLN | 153.25% |
| 2011 | 3.71 Million PLN | 64.28% |
| 2010 | 2.25 Million PLN | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -3.99 Million PLN | -0.63% |
| 2024 Q1 | -4.42 Million PLN | -288.06% |
| 2023 Q4 | -1.13 Million PLN | -192.15% |
| 2023 Q2 | -743 Thousand PLN | -124.35% |
| 2023 Q1 | 3.05 Million PLN | -55.32% |
| 2023 Q3 | 1.23 Million PLN | 266.35% |
| 2023 FY | - PLN | -88.91% |
| 2022 Q3 | 2.92 Million PLN | -75.07% |
| 2022 Q1 | -5.65 Million PLN | 92.43% |
| 2022 FY | - PLN | 128.7% |
| 2022 Q4 | 6.82 Million PLN | 133.76% |
| 2022 Q2 | 11.71 Million PLN | 307.22% |
| 2021 Q3 | 569 Thousand PLN | 160.08% |
| 2021 Q2 | -947 Thousand PLN | -181.71% |
| 2021 Q1 | 1.15 Million PLN | 118.85% |
| 2021 FY | - PLN | -269.58% |
| 2021 Q4 | -74.65 Million PLN | -13220.39% |
| 2020 FY | - PLN | -207.63% |
| 2020 Q3 | -7.22 Million PLN | -152.45% |
| 2020 Q1 | -3.72 Million PLN | -1769.35% |
| 2020 Q4 | -6.14 Million PLN | 14.86% |
| 2020 Q2 | -2.86 Million PLN | 23.12% |
| 2019 Q3 | 3.23 Million PLN | -40.57% |
| 2019 Q4 | -199 Thousand PLN | -106.16% |
| 2019 FY | - PLN | -50.4% |
| 2019 Q1 | 10.02 Million PLN | -28.55% |
| 2019 Q2 | 5.43 Million PLN | -45.78% |
| 2018 Q1 | 9.92 Million PLN | -10.46% |
| 2018 FY | - PLN | -28.49% |
| 2018 Q4 | 14.03 Million PLN | 119.67% |
| 2018 Q3 | 6.39 Million PLN | -9.61% |
| 2018 Q2 | 7.06 Million PLN | -28.79% |
| 2017 Q4 | 11.08 Million PLN | -35.13% |
| 2017 Q1 | 5.24 Million PLN | -85.11% |
| 2017 FY | - PLN | -0.56% |
| 2017 Q2 | 19.84 Million PLN | 278.76% |
| 2017 Q3 | 17.09 Million PLN | -13.89% |
| 2016 Q3 | 9.65 Million PLN | -37.53% |
| 2016 FY | - PLN | 109.53% |
| 2016 Q4 | 35.18 Million PLN | 264.33% |
| 2016 Q1 | -6.09 Million PLN | -185.49% |
| 2016 Q2 | 15.45 Million PLN | 353.61% |
| 2015 FY | - PLN | 33.81% |
| 2015 Q1 | 6.56 Million PLN | 65.43% |
| 2015 Q4 | 7.12 Million PLN | 45.7% |
| 2015 Q3 | 4.89 Million PLN | -29.0% |
| 2015 Q2 | 6.89 Million PLN | 4.99% |
| 2014 Q1 | 4.77 Million PLN | 39.09% |
| 2014 Q2 | 4.8 Million PLN | 0.68% |
| 2014 Q3 | 5.23 Million PLN | 8.82% |
| 2014 Q4 | 3.96 Million PLN | -24.12% |
| 2014 FY | - PLN | 39.17% |
| 2013 Q3 | 3.76 Million PLN | 11.37% |
| 2013 FY | - PLN | 43.57% |
| 2013 Q2 | 3.38 Million PLN | 7.1% |
| 2013 Q1 | 3.15 Million PLN | 1.96% |
| 2013 Q4 | 3.43 Million PLN | -8.88% |
| 2012 Q4 | 3.09 Million PLN | 22.85% |
| 2012 Q1 | 1.72 Million PLN | 0.0% |
| 2012 FY | - PLN | 153.25% |
| 2012 Q2 | 2.15 Million PLN | 24.78% |
| 2012 Q3 | 2.52 Million PLN | 17.08% |
| 2011 FY | - PLN | 64.28% |
| 2010 FY | - PLN | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Adiuvo Investments S.A. | -5.08 Million PLN | 143.953% |
| Genomtec S.A. | -7.75 Million PLN | 128.816% |
| Medinice S.A. | -4.72 Million PLN | 147.282% |
| Synektik Spólka Akcyjna | 125.43 Million PLN | 98.218% |